HopeStage
Back to all studies
RecruitingNCT07387796

Mood and appetite during a pause and restart of tirzepatide

About this titleRead the official source — NCT07387796
Interventional studyAges 18–70United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

What will I do during this study?

The protocol includes: Having brain scans.

Listed locations
DallasSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: October 2026
Recruitment status
Recruiting
Enrollment listed in the registry
40
Sponsor
The University of Texas at Dallas
Sponsor type
University
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT07387796
Official title
Show the full official title

Clinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation

Recruitment & locations

Currently recruiting

Dallas

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What will I need to do?

You will have brain scans.

Will I need to travel?

The study requires in-person visits.

Who is behind this study?

The study sponsor is The University of Texas at Dallas, a university.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies